Results by group16

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 16 of 16

Outcome	Group	Category	Value	Spread	Units
Response of Liver Metastases	Immunoembolization	Complete response (CR)	0		participants
Response of Liver Metastases	Plain Embolization	Complete response (CR)	0		participants
Response of Liver Metastases	Immunoembolization	Partial response (PR)	5		participants
Response of Liver Metastases	Plain Embolization	Partial response (PR)	3		participants
Response of Liver Metastases	Immunoembolization	Stable disease (SD)	12		participants
Response of Liver Metastases	Plain Embolization	Stable disease (SD)	19		participants
Response of Liver Metastases	Immunoembolization	Progression (PD)	8		participants
Response of Liver Metastases	Plain Embolization	Progression (PD)	5		participants
Overall Response Rate	Immunoembolization		21.2	90% Confidence Interval 10.3 to 30.5	percentage of participants
Overall Response Rate	Plain Embolization		16.7	90% Confidence Interval 6.3 to 26.9	percentage of participants
Overall Survival	Immunoembolization		21.5	95% Confidence Interval 18.5 to 24.8	months
Overall Survival	Plain Embolization		17.2	95% Confidence Interval 11.9 to 22.4	months
Median Progression Free Survival	Immunoembolization		3.9	95% Confidence Interval 3.5 to 4.3	months
Median Progression Free Survival	Plain Embolization		5.9	95% Confidence Interval 5.5 to 6.2	months
Systemic Progression Free Survival	Immunoembolization		10.4	95% Confidence Interval 7.5 to 13.2	months
Systemic Progression Free Survival	Plain Embolization		7.1	95% Confidence Interval 5.0 to 9.1	months

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00661622/results